Adaptive Biotechnologies: The MRD Separation Creates A Pure-Play Compounder (NASDAQ:ADPT)
· seekingalpha.com
Adaptive Biotechnologies (ADPT) pivots to pure-play MRD diagnostics as clonoSEQ adoption, margins & backlog surge.
My current bullish outlook on Adaptive Biotechnologies Corporation ( ADPT ) stems from the economic and financial change in the business rather than the science...